Ocular Oncology

The Association for Research in Vision and Ophthalmology (ARVO) is the largest and most respected eye and vision research organization in the world. Members include nearly 10,000 researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. In an insightful interview with touchOPHTHALMOLOGY, the […]

The objective of future treatment for retinoblastoma in children is to improve eye salvage rates. Dr Jesse Berry (Children’s Hospital Los Angeles, University of Southern California, Keck School of Medicine, CA, USA) talks about the current treatment landscape for this disease. The presentation, ‘Tall dark and uh-oh: an ocular oncology update’ was presented at Hawaiian […]

The field of ocular oncology is rapidly changing, according to a presentation at Hawaiian Eye 2022. It was a pleasure to speak with Dr Basil K Williams (University of Cincinnati, Cincinnati, OH, USA) on the topic of retinoblastoma and its challenges, and treatment options for uveal melanoma. The abstract entitled What’s New in the World […]

The field of ocular oncology is rapidly changing, according to a presentation at Hawaiian Eye 2022. We were delighted to speak with Dr Basil K Williams (University of Cincinnati, Cincinnati, OH, USA) about new developments in the field of ocular oncology. The abstract entitled What’s New in the World of Ocular Oncology? was presented at […]

It was a pleasure to meet Rumana Hussain (Liverpool University Hospital, Liverpool, UK) to discuss the results of her study into the mortality risks of genetically high-risk uveal melanomas, and the implications for future treatment paradigms. Questions What is known about the mortality risks of genetically high-risk uveal melanomas (UM)? (00:20) What were the aims […]